Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients

In an earlier study, we have demonstrated a high clinical and pathologic response rate of neoadjuvant paclitaxel (P) and cisplatin (C) for patients with locally advanced breast cancer (LABC). The current phase II study includes larger number of patients who had longer follow-up. A total of 126 conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzat, A A, Ibrahim, E M, Ajarim, D S, Rahal, M M, Raja, M A, Tulbah, A M, Al-Malik, O A, Al-Shabanah, M, Sorbris, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409621/
https://www.ncbi.nlm.nih.gov/pubmed/14997191
http://dx.doi.org/10.1038/sj.bjc.6601616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409621/
https://www.ncbi.nlm.nih.gov/pubmed/14997191
http://dx.doi.org/10.1038/sj.bjc.6601616

Ejemplares similares